Search for a command to run...
Chandan Healthcare Ltd. shows potential with a high ROE and low debt, but lacks revenue growth and profitability compared to its peers. Companies like Max Healthcare and Apollo Hospitals are strong performers, but others like Fortis and Aster DM are overvalued with weak fundamentals. Overall, a cautious approach is recommended for investors considering this sector.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
CHANDAN | - | - | 0.00 | 36.75% | 1.02 |
MAXHEALTH | ₹1,179.65 | ₹1,14,679.30Cr | 163.58 | 16.26% | 0.14 |
APOLLOHOSP | ₹7,676.95 | ₹1,10,383.03Cr | 85.15 | 21.19% | 0.67 |
FORTIS | ₹924.85 | ₹69,822.29Cr | 1094.63 | 12.01% | 0.11 |
MEDANTA | ₹1,395.25 | ₹37,474.60Cr | 81.26 | 20.50% | 0.10 |
NH | ₹1,784.05 | ₹36,459.02Cr | 84.56 | 21.62% | 0.61 |
ASTERDM | ₹605.10 | ₹30,225.53Cr | 5.05 | 11.46% | 0.19 |